Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

MediWound Ltd. (MDWD) Market Cap & Valuation Ratios

MediWound Ltd. (MDWD) has a market cap of $154.0M and a price-to-sales ratio of 13.0, with earnings according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

MDWDMediWound Ltd.Follow MDWD — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
154.0M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
17 Nov, in 24 days

Peers

biotechnology · nearest by market cap · trailing 12 months
CompanyMkt cap, $BP/EEV/SalesEV/EBITDAFCF yieldRev. growthOp. marginROIC
MDWD0.2—12.6——-40%-268%-126%
ADCT0.2—1.0——+3%-125%—
KRRO0.2—25.8——-62%—-138%
TRDA0.2—15.5——-94%—-80%
SION0.2——————-44%
CHRS0.2—1.7——+61%-312%—
UPB0.2————+16%—-61%
RNA0.1———————
CDXS0.1—1.6—-8.7%+36%-36%-48%
CMPX0.1——————-81%
NKTX0.1——————-50%
Median of these 10—1.7—-8.7%+10%-125%-61%

; EV/Sales 12.6 vs. 1.7.

Growth vs. price

each dot a company · hover or tap for values

MediWound Ltd. — questions

What is MediWound Ltd.'s market cap?
$154.0M.
What is MediWound Ltd.'s price-to-sales ratio?
13.0.

Every figure on this page comes from MediWound Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.